SIAH1/CTR9 axis promotes the epithelial–mesenchymal transition of hepatocellular carcinoma

作者：Zhiyi Liu, Pengchao Luo, Kuan Cao, Qinghe Hu, Bin Hu, Licheng Cui, Xiaotian Wang, Hengliang Shi, Bin Zhang, Renhao Wang · 发表于：Carcinogenesis · 年份：2023 · DOI：10.1093/carcin/bgad021 · 被引用次数：11 · 研究领域：Ubiquitin and proteasome pathways、Cancer-related Molecular Pathways、RNA modifications and cancer

SIAH1 has been reported to participate in several human cancers, including hepatocellular carcinoma (HCC). However, the effect of SIAH1 on the epithelial-mesenchymal transition (EMT) has not been reported in HCC cells. Here, we discovered the inhibitory effect of SIAH1 on HCC cell migration and invasion, which was related with regulating EMT. Molecularly, a yeast two-hybrid experiment indicated that Cln Three Requiring 9 (CTR9) was a potential interacting protein of SIAH1, which was further verified by co-immunoprecipitation assays. Furthermore, SIAH1 inhibited the EMT of HCC cells through negatively regulating CTR9. Importantly, CTR9 was ubiquitinated and degraded by SIAH1 via the proteasome pathway in HCC cells. Additionally, it was showed that SIAH1 mainly mediated the K48-linked polyubiquitination on CTR9. Finally, the protein level of CTR9 was found to be inversely correlated with SIAH1 in human HCC tissues. Summed up all together, these findings reveal that SIAH1/CTR9 axis promotes the EMT of HCC cells and is a promising therapeutic target for HCC therapy.